Search

everythinglearnresearchcommunity

for

Search:↓

Ginkgolide B and bilobalide help mink hair grow by making skin cells healthier and boosting a key growth protein.

Tangent screens help detect visual field defects from vigabatrin.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Targeting FGFR-1 with antisense oligonucleotides may help treat baldness by increasing hair follicle activity.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

The committee decided not to approve the drug due to low effectiveness and high risks.

A new DSG4 gene mutation causes hair defects in a young girl.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Gefitinib can cause hair and eyebrow darkening.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.